Brief: Cytotools successfully places capital increase

bioXXmed AG

20/10/2015 13:01

Oct 20 (Reuters) - Cytotools AG  T5OG.DE  
    * Successfully places capital increase and creates the prerequisite for the extension of 
clinical development in the USA 
    * Gross proceeds in the amount of 4.0 million euro ($4.55 million) ensures expansion of 
clinical trials in the USA for the wound healing drug DermaPro 
 
Source text for Eikon:  ID:nEQ9506Lna  
Further company coverage:  T5OG.DE  
 
($1 = 0.8794 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))